PARSIPPANY, New Jersey, March 14, 2012 /PRNewswire/ -- Ingenol mebutate was proven efficacious with a once-daily application for

PARSIPPANY, N.J., Feb.

COPENHAGEN, Denmark, January 26, 2012 /PRNewswire/ -- LEO Pharma today announced that Picato(R) (ingenol mebutate) gel (0.015%, 0.05%) has been approved by the US Food

New research shows the NSAID Celebrex may help prevent some non-melanoma skin cancers from developing in patients who have pre-cancerous actinic keratoses lesions and are at high risk for having the disease.

WILMINGTON, Mass., May 7 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(®) (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan(®) Photodynamic Therapy (PDT), today announced that the United States Patent and Trademark Office has issued a notice of allowance for a key patent related to its proprietary PDT light source, the BLU-U(®), Blue Light Photodynamic Therapy Illuminator.